Clinical Trial Update: BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating BPX-01 minocycline 1% topical gel for reducing Propionibacterium acnes in acne vulgaris; study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• BPX-01 Minocycline 1% topical gel (minocycline)

Snippet

Sponsor: BioPharmX, Inc. | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2017-09-14